Selina Casalino: Genomic Counseling Model Enhances Knowledge and Reduces Conflict in Genome Sequencing
Genetics Adviser reshared the post by Selina Casalino, Research Project Manager and Genetic Counsellor at Sinai Health on LinkedIn, adding:
“Check out this article highlighting real world evidence on the effectiveness of Genetics Adviser in scaling the delivery of population genomic screening among the general public.
We aim to revolutionize the delivery of and access to Precision Medicine with Digital Health alongside our health system and industry partners – this is just one example of that.
Genetics in Medicine Open, Sinai Health, Unity Health Toronto and CIHR Institute of Genetics.
Selina Casalino, MSc, CCGC, Yvonne Bombard, Marc Clausen and Anusha Gandhi.”
Quoting Selina Casalino’s post:
“Pleased to share our Genomic Counselling Model (GCM) for supporting pre-test counselling for genome sequencing (GS) at scale through the GENCOV study, published in Genetics in Medicine.
Our findings support that our GCM, which includes counselling support through group webinars and the Genetics Adviser, increases knowledge and reduces decisional conflict in participants undergoing GS from the general population.
We also found that most people wanted to learn all possible types of results from GS.”
Title: A Genomic Counseling Model for Population-Based Sequencing: A Pre-Post Intervention Study
Authors: Selina Casalino, Chloe Mighton, Marc Clausen, Erika Frangione, Navneet Aujla, Georgia MacDonald, Juliet Young, Chun Yiu Jordan Fung, Gregory Morgan, Saranya Arnoldo, Erin Bearss, Alexandra Binnie, Bjug Borgundvaag, Sunakshi Chowdhar, Marc Dagher, Luke Devine, Steven Marc Friedman, Limin Hao, Zeeshan Khan, William Lane, Elisa Lapadula, Matthew Lebo, David Richardson, Seth Stern, Lisa Strug, Ahmed Taher, Elena Greenfeld, Abdul Noor, Hanna Faghfoury, Jennifer Taher, Yvonne Bombard and Jordan Lerner-Ellis
Yvonne Bombard, Canada Research Chair at Unity Health Toronto and a Professor at the University of Toronto, also shared the post on LinkedIn:
“I may be biased but this is pretty huge for increasing access and impact of precision medicine especially beyond our clinics for population health.
Delivering Precision Medicine at scale.”
Yvonne Bombard is a Canada Research Chair at Unity Health Toronto and a Professor at the University of Toronto. She is also the CEO and Co-Founder of Genetics Adviser and a Research Scientist at the Li Ka Shing Knowledge Institute, St. Michael’s Hospital. Her research interests include genomics, health services, and policy research.
More posts featuring Genetics Adviser.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023